Literature DB >> 12831788

Drug metabolites in safety testing.

Kenneth L Hastings, Jeri El-Hage, Abigail Jacobs, John Leighton, David Morse, Robert E Osterberg.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12831788     DOI： 10.1016/s0041-008x(03)00150-9

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN： 0041-008X            Impact factor:   4.219


× No keyword cloud information.
  3 in total

Review 1.  The conduct of drug metabolism studies considered good practice (I): analytical systems and in vivo studies.

Authors:  Xiaodong Liu; Lee Jia
Journal:  Curr Drug Metab       Date:  2007-12       Impact factor: 3.731

2.  Meeting report: metabolites in safety testing (MIST) symposium-safety assessment of human metabolites: what's REALLY necessary to ascertain exposure coverage in safety tests?

Authors:  Hongying Gao; Abigail Jacobs; Ronald E White; Brian P Booth; R Scott Obach
Journal:  AAPS J       Date:  2013-07-03       Impact factor: 4.009

3.  In vivo-formed versus preformed metabolite kinetics of trans-resveratrol-3-sulfate and trans-resveratrol-3-glucuronide.

Authors:  Satish Sharan; Otito F Iwuchukwu; Daniel J Canney; Cheryl L Zimmerman; Swati Nagar
Journal:  Drug Metab Dispos       Date:  2012-07-17       Impact factor: 3.922
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.